Anders Nygren's Biography

Anders Nygren, Senior Director, Research and Development, Agena Biosciences

Dr. Nygren serves as the Senior Director, Research and Development at Agena Biosciences located in San Diego, USA. He joined Agena Bioscience, formerly Sequenom in 2008, serving in various roles within the R&D department. Since joining Agena Biosciences Dr Nygren has focused of on different aspects of nucleic acid analysis with emphasis on ultrasensitive detection of somatic mutations isolated from tumor and circulating cell free DNA. Prior to joining Agena/Sequenom Dr Nygren was part in the commercialization team of the multiplex ligation dependent probe amplification (MLPA) technology for relative quantification of nucleic acid copy numbers and is the inventor of Methylation-Specific MLPA. Dr. Nygren received his Master of Science in Molecular Biotechnology at Uppsala University and his PhD in clinical chemistry at the Free University of Amsterdam.